Quattro Financial Advisors’s The Oncology Institute TOI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-162,724
Closed -$186K 91
2025
Q1
$186K Hold
162,724
0.06% 79
2024
Q4
$113K Hold
162,724
0.03% 84
2024
Q3
$52.6K Buy
162,724
+106,764
+191% +$44.2K 0.01% 77
2024
Q2
$25.7K Hold
55,960
0.01% 75
2024
Q1
$88.4K Buy
+55,960
New +$106K 0.03% 78

Other funds holding TOI

Quattro Financial Advisors's TOI Position: Q2 2025 in Review

Quattro Financial Advisors sold out of The Oncology Institute (TOI) in Q2 2025, closing a stake of 162,724 shares — an estimated $186K sold.

Quattro Financial Advisors first reported a position in TOI in Q1 2024 and held it in 5 quarters. The position peaked at $186K in Q1 2025. 79 funds tracked by Wall St. Rank hold TOI as of Q2 2025.

  • Quattro Financial Advisors reported no remaining The Oncology Institute position as of Q2 2025 after selling out during the quarter.
  • Quattro Financial Advisors sold 162,724 The Oncology Institute shares in Q2 2025, an estimated $186K.
  • Quattro Financial Advisors first reported a position in The Oncology Institute in Q1 2024 and held it in 5 quarters.
  • Quattro Financial Advisors's The Oncology Institute position peaked at $186K in Q1 2025.
  • 79 funds tracked by Wall St. Rank held The Oncology Institute as of Q2 2025.

Based on Quattro Financial Advisors's 13F filing for Q2 2025, filed 21 Jul 2025.